Tvardi Therapeutics, Inc. (TVRD)

Tvardi Therapeutics, Inc. (TVRD) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $13.7M; returns 1 day -3.3%, 1 week -6.9%, 1 year -81.8%.

Tvardi Therapeutics, Inc. (TVRD) is a clinical-stage biopharmaceutical company based in Sugar Land, Texas, focused on developing novel, oral, small molecule therapies that target Signal Transducer and Activator of Transcription 3 (STAT3). STAT3 is a central mediator implicated in the progression of fibrosis-driven diseases and various cancers.

Groups TVRD belongs to

• Biotechnology
• Clinical Stage Biotech
• Biopharmaceutical
• Healthcare
• Fibrosis
• Oncology
• Clinical Stage
• Pharmaceuticals
• Life Sciences
• Cancer Therapeutics

TVRD financial model: income statement, cash flow and balance sheet